The global
coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a positive-sense RNA virus. How the host immune system senses and responds to
SARS-CoV-2 infection remain largely unresolved. Here, we report that
SARS-CoV-2 infection activates the innate immune response through the cytosolic
DNA sensing cGAS-
STING pathway.
SARS-CoV-2 infection induces the cellular level of 2'3'-cGAMP associated with
STING activation. cGAS recognizes
chromatin DNA shuttled from the nucleus as a result of cell-to-cell fusion upon
SARS-CoV-2 infection. We further demonstrate that the expression of spike
protein from SARS-CoV-2 and ACE2 from host cells is sufficient to trigger cytoplasmic
chromatin upon cell fusion. Furthermore, cytoplasmic
chromatin-cGAS-
STING pathway, but not MAVS-mediated
viral RNA sensing pathway, contributes to
interferon and pro-inflammatory gene expression upon cell fusion. Finally, we show that cGAS is required for host
antiviral responses against SARS-CoV-2, and a
STING-activating compound potently inhibits viral replication. Together, our study reported a previously unappreciated mechanism by which the host innate immune system responds to
SARS-CoV-2 infection, mediated by cytoplasmic
chromatin from the infected cells. Targeting the cytoplasmic
chromatin-cGAS-
STING pathway may offer novel therapeutic opportunities in treating
COVID-19. In addition, these findings extend our knowledge in host defense against
viral infection by showing that host cells' self-
nucleic acids can be employed as a "danger signal" to alarm the immune system.